Isolation of Escherichia coli bacteriophage from water environment by lysis method
Main Article Content
Abstract
The World Health Organization (WHO) classifies Vietnam as one of the countries with the highest antibiotic resistance in the world, in which Escherichia coli is also one of the most resistant bacteria. Researchers have sought to use bacteriophages, or phages for short, as an alternative to antibiotics for bacterial infections. Previous studies have shown that phages have cured 90% of chronic viral infections (meningitis, peritonitis, osteomyelitis) in human caused by bacterial pathogens antibiotic resistance such as Staphylococcus aureus, Pseudomonas aeruginosa, E. coli. In Vietnam, the studies on phages are still limited. Our study was conducted with the objective of isolating Bacteriophage from wastewater environment able to degraded E. coli bacteria. Conclusion: successfully isolated bacteriophages, capable of specifically degrading human pathogenic E. coli bacteria from wastewater environment, is a premise for antibiotic resistance therapy in the future.
Article Details
Keywords
antibiotic resistance, bacteriophage, phage, E. coli
References
2. Knezevic P, Hoyle NS, Matsuzaki S, et al. Editorial: Advances in Phage Therapy: Present Challenges and Future Perspectives. Frontiers in Microbiology. 2021-June-04 2021;12(1390).
3. Jensen EC, Schrader HS, Rieland B, et al. Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Applied and environmental microbiology. Feb 1998;64(2):575-580.
4. Abedon ST, Kuhl SJ, Blasdel BG, et al. Phage treatment of human infections. Bacteriophage. Mar 2011;1(2):66-85.
5. Carlton RM. Phage therapy: past history and future prospects. Archivum immunologiae et therapiae experimentalis. 1999;47(5):267-274.
6. Cerveny KE, DePaola A, Duckworth DH, et al. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infection and immunity. Nov 2002;70(11):6251-6262.
7. DePaola A, McLeroy S, McManus G. Distribution of Vibrio vulnificus phage in oyster tissues and other estuarine habitats. Applied and environmental microbiology. Jun 1997;63(6):2464-2467.
8. Yen JY, Broadway KM, Scharf BE. Minimum requirements of flagellation and motility for infection of Agrobacterium sp. strain H13-3 by flagellotropic bacteriophage 7-7-1. Applied and environmental microbiology. Oct 2012;78(20):7216-7222.
9. Kropinski AM, Mazzocco A, Waddell TE, et al. Enumeration of bacteriophages by double agar overlay plaque assay. Methods in molecular biology (Clifton, N.J.). 2009;501:69-76.
10. Tarchouna M, Ferjani A, Ben-Selma W, et al. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Jun 2013;17(6):e450-453.
11. Louie M, de Azavedo JC, Handelsman MY, et al. Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. Infection and immunity. Oct 1993;61(10):4085-4092.
12. Alves DR, Gaudion A, Bean JE, et al. Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Applied and environmental microbiology. Nov 2014;80(21):6694-6703.
13. Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends in microbiology. Feb 2009;17(2):66-72.
14. Gómez P, Buckling A. Bacteria-phage antagonistic coevolution in soil. Science (New York, N.Y.). Apr 1 2011;332(6025):106-109.
15. Griffiths RI, Thomson BC, James P, et al. The bacterial biogeography of British soils. Environmental microbiology. Jun 2011;13(6):1642-1654.
16. Koskella B, Meaden S. Understanding bacteriophage specificity in natural microbial communities. Viruses. Mar 11 2013;5(3):806-823.
17. Dias RC, Moreira BM, Riley LW. Use of fimH single-nucleotide polymorphisms for strain typing of clinical isolates of Escherichia coli for epidemiologic investigation. Journal of clinical microbiology. Feb 2010;48(2):483-488.